Human pluripotent stem cells (PSCs) show epiblast-type pluripotency that is maintained with ACTIVIN/FGF2 signaling. Here, we report the acquisition of a unique stem cell phenotype by both human ES cells (hESCs) and induced pluripotent stem cells (iPSCs) in response to transient (24-36 h) exposure to bone morphogenetic protein 4 (BMP4) plus inhibitors of ACTIVIN signaling (A83-01) and FGF2 (PD173074), followed by trypsin dissociation and recovery of colonies capable of growing on a gelatin substratum in standard medium for human PSCs at low but not high FGF2 concentrations. The self-renewing cell lines stain weakly for CDX2 and strongly for NANOG, can be propagated clonally on either Matrigel or gelatin, and are morphologically distinct from human PSC progenitors on either substratum but still meet standard in vitro criteria for pluripotency. They form well-differentiated teratomas in immune-compromised mice that secrete human chorionic gonadotropin (hCG) into the host mouse and include small areas of trophoblast-like cells. The cells have a distinct transcriptome profile from the human PSCs from which they were derived (including higher expression of NANOG, LEFTY1, and LEFTY2). In nonconditioned medium lacking FGF2, the colonies spontaneously differentiated along multiple lineages, including trophoblast. They responded to PD173074 in the absence of both FGF2 and BMP4 by conversion to trophoblast, and especially syncytiotrophoblast, whereas an A83-01/PD173074 combination favored increased expression of HLA-G, a marker of extravillous trophoblast. Together, these data suggest that the cell lines exhibit totipotent potential and that BMP4 can prime human PSCs to a self-renewing alternative state permissive for trophoblast development. The results may have implications for regulation of lineage decisions in the early embryo.
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biological sciences | developmental biology | pluripotent stem cells | totipotent | trophoblast M ouse ES cells, the "naive" type, are obtained from outgrowths of the inner cell mass/early epiblast of blastocysts (1) and are dependent on the growth factor leukemia inhibitory factor (LIF) for maintenance of pluripotency. They may be passaged by dispersal to single cells with trypsin and can be maintained on a gelatin substratum. Human ES cells (hESCs) and induced pluripotent stem cells (iPSCs) form flattened colonies that resemble, and are considered functionally comparable to, pluripotent cells derived from the mouse epiblast, or "primed"-type stem cells (1) (2) (3) (4) (5) . hESCs and iPSCs are maintained with activators of two signaling pathways: the BMP receptor type-1A (BMPR1A) (ALK3) pathway via ACTIVIN and the mitogen-activated protein kinase kinase/ERK signaling pathway via FGF2 (6) (7) (8) . They do not readily survive single-cell dispersion by proteinases; rather, they must be passaged by either mechanical breakage of colonies after dispase treatment or gentle dissociation with chelating agents in presence of Rho-associated kinase (ROCK) inhibitors to small clusters of cells. Moreover, they can be grown on a feeder layer or substratum coated with Matrigel (Corning), but not gelatin. Both mouse and hESCs and iPSCs are considered pluripotent and capable of differentiating to the three embryonic lineages but are generally not regarded as totipotent, because they are not considered to contribute to extraembryonic cell types (1) . However, there are several reports indicating that mouse ESCs, given a suitable stimulus, can differentiate to trophoblast (9) (10) (11) .
hESCs and iPSCs will also differentiate to the extraembryonic trophoblast lineage either when they are allowed to form embryoid bodies (12, 13) or when BMP4, or certain of its homologs, including BMP2, BMP5, BMP7, BMP10, and BMP13, are present in the medium and FGF2 is absent (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . The BMPdriven process is accelerated and directionality is enhanced if the signaling pathways that maintain the pluripotent state are inhibited (25) . Trophoblast markers become up-regulated as differentiation proceeds, and an invasive HLA-G + population and a syncytial cell population expressing CGA, CGB, ERVW1, and other signature genes gradually emerge (17, 18, (25) (26) (27) . The colonies of human cells release human chorionic gonadotropin (hCG), placental growth factor (PGF), placental lactogen (CSH1), and progesterone into the medium (25) . All of this trophoblast differentiation can occur in either a complex medium conditioned by mouse embryonic fibroblasts (MEFs) or in a chemically defined medium (25) . On the other hand, if FGF2 is not removed from the culture medium before addition of BMP4, a more complex differentiation pattern materializes, with both mesoderm and endoderm, as well as extraembryonic tissues, emerging in amounts that appear to depend on the relative concentrations of BMP4, ACTIVIN, and FGF2 (5). Consequently, it might be inferred that both mouse Significance Human ES cells (ESCs) and induced pluripotent stem cells (iPSCs) can differentiate along all the major cell lineages of the embryo proper, but there is evidence that they can also give rise to extraembryonic placental trophoblast. This observation is controversial because human ESCs (hESCs) are considered to arise from a part of the embryo that does not contribute to trophoblast. Here, we describe stable, self-renewing stem cell lines derived from hESCs and iPSCs by brief exposure to bone morphogenetic protein 4 (BMP4) that appear poised to differentiate readily along all the main developmental cell lineages, including placental trophoblast. BMP4 signaling may thus play a role in the early embryo by establishing a cell state permissive for trophoblast development.
ESCs and hESCs, when placed in an appropriate environment, can expand their developmental potential and differentiate to trophoblast.
The ability of BMP4 to initiate trophoblast differentiation from hESCs has been puzzling. In naive-type ESCs, BMP4 augments pluripotency rather than destabilizing it (28, 29) , although mouse epiblast-derived ESCs in absence of ACTIVIN signaling also respond to BMP4 by expressing markers characteristic of primitive endoderm and trophoblast (2) . On the other hand, embryologists have expressed doubt as to whether "epiblast"-type stem cells could give rise to trophoblast, a lineage that segregates from the inner cell mass before the epiblast has formed (30, 31) .
Here, we present evidence that BMP4 acts to enhance the potency of hESCs and iPSCs, making them readily capable of forming both embryonic and trophoblast lineages. Previously, we reported that only a transient, 24-h exposure to BMP4 was necessary for hESC colonies to commit to trophoblast. Thereafter, the ACTIVIN signaling inhibitor A83-01 and FGF2 signaling inhibitor PD173074, in the complete absence of BMP4, were sufficient to promote a full display of markers for differentiated trophoblast sublineages (25) . The goal of the current study was to maintain stable cell lines in the state reached just after brief exposure to BMP4, A83-01, and PD173074 (BAP). We had initially predicted that these cells would be present early in the trophoblast lineage, possibly even in trophoblast stem cells. Instead, these lines represent a unique type of human pluripotent stem cell (PSC).
Results
Isolation of BAP-Converted ESC and iPSC Lines. H1 (WA01) cells, H9 (WA09) cells, and iPSC cells were routinely cultured on a Matrigel substratum on mTeSR1 medium (STEMCELL Technologies) (32) . To initiate differentiation toward trophoblast, colonies were subcultured; on the following day, the culture medium was changed from the defined mTeSR1 medium to the MEFconditioned DMEM/F12/KOSR medium (MEF-CM), which contains lower concentrations of recombinant FGF2 (4 ng/mL) than mTeSR1 medium and no supplementary TGF-β (Fig. 1A) . After a further 24 h, the medium was changed again to one lacking FGF2 but containing BMP4 (10 ng/mL), the ALK4/5/7 inhibitor A83-01 (1 μM), and the FGF2-signaling inhibitor PD173074 (0.1 μM) (BAP treatment) in nonconditioned DMEM/F12/KOSR medium (hESCM). Control cultures continued to be grown in the same basal medium in the presence of FGF2 and in the absence of BMP4 and inhibitors. At this stage, the BAP cultures remained negative for KRT7, but many cells, particularly on the periphery of the colonies, stained weakly for CDX2 (Fig. 1B) , although they converted completely to a KRT7 + /CDX2 + state if kept in this medium for a further day (25) .
After the initial 24-h exposure to BAP conditions, the culture medium was changed to MEF-CM containing FGF2 (4 ng/mL) (Fig. 1A) . After 24 h on this medium, all cells stained positively for CDX2 but KRT7 staining was weak and less uniform, with many areas of the colonies remaining negative for this antigen (Fig. 1C, Upper) . After 3 d, defined patches of CDX2 + /KRT7 − cells were evident and appeared to be organizing into colonies (Fig. 1C, Lower) . These regions of clustered cells that stained for CDX2 were encompassed by KRT7 + cells. At day 4, soon after these disorganized colonies became evident, the cultures were dispersed into single cells with TrypLE and passaged at a 1:2 ratio onto 0.1% gelatin-coated culture wells in the same MEF-CM with 10 ng/mL FGF2.
In most experiments, well-formed colonies began to emerge within 3-8 d (Fig. 1D) , and where colonies had not emerged so early, they did so after the next passage. Thereafter, cells from colonies can be passaged approximately every 3 d at a ratio of 1:3 or 1:4. To distinguish these new cell lines from their progenitor PSC lines, each is provided with the same cell line designation followed by the subscript BP (BAP-primed). Hence, the derivative cell lines from H1 cells are named H1 BP cells. That these H1 BP colonies are distinct from the precursor H1 cells is evident from their comparative morphologies. For example, the H1 BP cells appeared to be flatter and to have a larger surface area, reflecting a greater cytoplasm-to-nuclear ratio, than the parental H1 cells (Fig. 3 A and E). They also displayed more distinct cell margins (Fig. S1A) . These morphological differences were also observed during culture on Matrigel (Fig. 3E) , and so were not a consequence of a particular substratum. However, when H1 and H1 BP cells were evaluated for relative size after dispersion to single cells, their diameters did not differ [6.33 ± 0.17 μm for H1 cells vs. 6.17 ± 0.17 μm for H1 BP cells (n = 3, with each experiment performed on >5 × 10 5 cells)], suggesting that the differences evident during culture were a reflection of their respective interactions with the substratum. When H1 BP colonies were dispersed to single cells by TrypLE and plated on a gelatin substratum, 73 ± 5% (n = 3) cells attached to the substratum within 24 h and formed well-developed colonies within 3 d (Table S1 ). By contrast, parental H1 cells did not survive complete dispersion to single cells by TrypLE and could not be propagated on a gelatin substratum ( Fig. S2 and Table S1 ). H1 cells passaged in the standard manner as small clumps (∼100 μm in diameter) by dispase treatment, followed by mechanical dissociation with a cutting tool, also failed to grow on gelatin (Fig. S2C) .
The protocol described above works successfully for H1 cells, H9 cells, and iPSCs (Fig. 2) , and it has been performed repeatedly with H1 cells (Fig. 2) . For each of the cell lines, colony self-renewal can be extended over multiple passages with no measurable change in population doubling times. However, extended passage (>25 passages) of H1 BP and H9 BP lines has led to variable degrees of chromosomal instability (Fig. S3) . For example H1 BP cells have been noted with trisomy 12 and other signs of chromosomal instability in late-passage cells when trypsin had been used for regular cell passage. H9 BP cells also show karyotype abnormalities (e.g., translocations involving chromosomes 8 and 18) as passage numbers are extended (Fig. S3) . Such aberrations associated with trypsin passage have been commonly noted in hESCs (33) . A more gentle dispersion to single cells with nonenzymatic reagents, rather than the continued use of trypsin, has so far provided chromosomal stability over 16 passages (Fig. S3) .
Colonies can also be derived if the initiating BAP conditions are extended to 36 h, but not to 48 h or beyond ( Fig. 2 and Fig.  S1B ). The emergence of colonies is also sensitive to the concentration of FGF2 in the culture medium. No lines have been successfully derived when FGF2 exceeded 10 ng/mL (Fig. 2 , conditions 3-5 and 10). Similarly, the H1 BP cells could neither be generated nor maintained in mTeSR1 medium, which contains high concentrations of FGF2 (100 ng/mL) ( Fig. 2 condition 6 ). H1 BP colonies can be generated, and subsequently maintained, on conditioned medium without supplemental FGF2 (Fig. 2 , conditions 2 and 11); however, as shown later (Fig. S1C) , such colonies stain less intensely for NANOG and POU5F1 than the ones grown with added FGF2. These results are consistent with the conclusion that the H1 BP cells require only low concentrations of FGF2, which can be supplied minimally in the MEF-CM (34) . Importantly, self-renewing H1 BP colonies could not be generated in nonconditioned ESC medium, even in presence of FGF2 (Fig. 2, condition 10 ), suggesting that in addition to FGF2, some other factor released by MEFs and present in conditioned medium is required for growth.
Finally, no colonies could be generated under conditions used to derive and maintain trophoblast stem cells from mouse conceptuses (35, 36) (Fig. 2, conditions 8 and 9 ). Colonies did form when FGF4 was used in association with MEF-CM, but there was no indication that this colony formation occurred more efficiently than when the FGF4 was omitted.
Phenotype of the BAP-Primed ESC and iPSC Lines. The PSC BP colonies were distinct in several features from the initiating H1 cells, H9 cells, and iPSCs ( Fig. 3A and Table S1 ). They were weakly positive for CDX2, negative for KRT7, but strongly positive for POU5F1 and NANOG ( Fig. 3B and Fig. S1 D and E). By contrast, the scattered surrounding cells still present in the cultures at early passage did not form colonies and were negative for POU5F1 and NANOG, but positive for KRT7, indicating they had probably converted to trophoblast. Two approaches were used to minimize the contribution of these trophoblast cells as culture continued. The first approach was to dissociate the colonies to single cells, such that no clumps were present, and then to allow the cell suspension to settle. Under these conditions, the larger KRT7 + cells sank more quickly, causing the upper layer to become enriched with cells from the colonies. When the latter were replated, the background of epithelial cells was markedly reduced (Fig. S1F ). The second approach, shown here for H1 BP cells but also successful with other lines, was to passage the cells repeatedly at a lower split ratio (1:6-1:8). Over extended passage, the cultures progressively lost the KRT7 + components and became composed solely of colonies similar to those colonies shown in Fig. S1F . Thus, the KRT7 + supplemental cells were not required to maintain H1 BP self-renewal.
The increased expression of POU5F1 and NANOG transcripts, inferred from immunohistochemistry ( Fig. 3B and Table S2 ), was confirmed by real-time quantitative PCR (qPCR) ( Fig. 3C and Table S3 ). Expression of POU5F1 and NANOG was higher in H1 BP cells than in H1 cells. CDX2, GATA3, and TFAP2A transcripts were also significantly up-regulated, but levels of all three were low, requiring more than 28 amplification cycles when the internal control, GAPDH, was detected after only about 17 cycles. Flow cytometry demonstrated that dissociated colonies of both H1 BP cells (passaged by single-cell dissociation) and H1 cells (passaged by mechanical dispersion but dissociated by TrypLE before fixing and staining for flow cytometry) were highly uniform in terms of expression of POU5F1 and were >99% negative for KRT7 staining (Fig. 3 F and G and Table S4 ). H1 BP colonies also provided a highly homogeneous population of cells positive for NANOG, whereas H1 cells were more heterogeneous for NANOG staining and included some cells that stained only weakly, if at all, for this transcription factor. These experiments have been repeated on at least three different occasions with similar outcomes. In the case of H1 BP cells, the flow cytometry was performed with different clonal populations of cells. Each was highly homogeneous in terms of POU5F1 and NANOG staining.
Western blot analysis performed on colony lysates verified that H1 BP cells expressed POU5F1, NANOG, SOX2, CDX2, and GATA3 ( Fig. 3D and Table S5 ). The up-regulation of NANOG, CDX2, and GATA3 in H1 BP cells relative to H1 cells was clearly evident in these Western blotting experiments. However, these data were not as clear-cut for H9 BP cells and iPSC BP . With the H9 BP cells, there appeared to be increased expression of POU5F1, NANOG, and SOX2 relative to the parental H9 cells (Fig. S1D , Left), but expression of CDX2 and GATA3 was much lower than noted in the H1 BP cell line. In iPSC BP /iPSC comparisons, expression of POU5F1, NANOG, and SOX2 was similar, whereas CDX2 expression was increased in iPSC BP (Fig. S1D, Right) . Despite these differences, both of these cell lines successfully survived complete proteolytic dispersion to single cells, could be maintained on a gelatin substratum (Fig. 2, conditions 16 and  17) , and displayed no sign of differentiation.
Microarray Analysis. RNA was isolated from control H1 cells, from H1 cells exposed to BAP conditions for 24 and 48 h, from H1 BP colonies picked individually at two different passage numbers (p7 and p18), and from H1 BP cells that had been allowed to differentiate spontaneously in the absence of FGF2 (Fig. 4A) . The latter cells are discussed in greater detail in the next section. Unsupervised hierarchical clustering and principal component analysis of the data (Fig. 4  A and B) showed that the H1 BP cells had distinct transcriptional profiles from the progenitor H1 cells and H1 cells treated with BAP for 24 h. H1 BP cells at different passage numbers had also diverged somewhat in terms of their gene expression profiles.
Analysis by the pluripotency test (PluriTest) (Fig. 4C) , a bioinformatics tool that provides an assessment of whether or not human cells are pluripotent by their expression of a relatively large number of gene markers consistently associated with hESCs and iPSCs (37) , indicated that the H1 BP cells had transcriptional profiles consistent with pluripotency and pluri-raw scores comparable to the pluripotency and pluri-raw scores of H1 cells. The novelty scores, which essentially measure deviation from the expected gene expression pattern of an idealized human pluripotent cell line, were also low. By contrast, the cultures of H1 cells that had been treated with BAP for 24 h and from which the H1 BP cells ultimately emerged had already diverged from their parental H1 cells and lost pluripotency. This drift from pluripotency was further accentuated after 48 h of BAP treatment.
A total of 110 genes were up-regulated greater than twofold in the two H1 BP cell samples relative to H1 cells ( Fig. S4 and Dataset S1). Among the most strongly up-regulated genes were NODAL, CER1 (which encodes cerberus, a BMP antagonist), F2RL1, LEFTY1, LEFTY2, GDF3, GAL, and SCGB3A2 (which encodes secretoglobin, a surfactant protein). In addition to these genes, there was significant up-regulation of at least two other potential trophoblast stem cell markers, namely, EOMES and TFAP2C, whose increased expression in the H1 BP colonies was confirmed by qPCR (Fig. 4D) .
Teratoma Formation. H1 cells, H1 BP cells, H9 cells, H9 BP cells, iPSCs, and iPSC BP all gave rise to teratomas in immunodeficient mice. In each case, the tumors included tissue representative of ectoderm (neural epithelium and melanin-producing cells), endoderm (gut-like epithelium accompanied by secretory glands), and mesoderm (muscle and cartilage tissues, shown for H1 BP and H9 BP cells in Fig. 5A ). Immunostaining of sections for KRT7, which is a broadly used marker for trophoblast, and for the transcription factor GATA3 revealed a few small regions of positive tissue adjacent to open, vacuole-like structures resembling lacunae of the early human placenta (Fig. 5B) . Such regions were also positive for CGA, and hence are potential trophoblast, but cellular detail was insufficient to determine whether syncytial structures were present (Fig. 5B) . A few regions within the tumors showed positive HLA-G and KRT7 staining (Fig. 5B) . The presence of HLA-G and CGB transcripts in the teratomas was confirmed by RT-PCR (Fig. 5C ). In addition to these potential indicators of trophoblast, mice carrying tumors derived from H1 BP or H9 BP cells, but not mice with H1 cell, H9 cell, or iPSC BP tumors, had serum concentrations of hCG significantly higher than control mice and mice harboring H1 and H9 teratomas (Fig. 5D) . Together, these data indicated that all of the cell lines were pluripotent and that the H1 BP and H9 BP teratomas contained small amounts of tissue that was possibly trophoblast.
In Vitro Differentiation. Although the PSC BP lines could self-renew, removal of FGF2 and replacement of the MEF-CM with nonconditioned ESC medium lacking FGF2 (hESCM) led to initiation of differentiation within the colonies (Fig. 6A and  Fig. S5A ). Within 10 d of culture in hESCM, many colonies possessed regions of cells that were positive for NESTIN, T (BRACHYURY), and SOX17 (Fig. 6A) . The colonies also release α-fetoprotein into the medium, consistent with a partial endodermal phenotype (Fig. S5B) . Additionally, there were regions that were positive for CGA and GATA2 (Fig.  6B) , and hence likely to be trophoblast. There was also considerable heterogeneity in colony morphologies and in the distribution of markers among the colonies within a particular culture well. The differentiated colonies produced hCG, progesterone, and PGF, although in relatively small amounts relative to when differentiation was driven by PD173074 (0.1 μM), A83-01 (1 μM), or both inhibitors together (Fig. 6E and Table  S6 ). Thus, all three main germ layers, as well as trophoblast, appeared to be represented among these differentiating colonies. The expression of additional markers for trophoblast (transcripts for CGB, PGF, and HLA-G) and their increased expression in differentiated H1 BP cells relative to undifferentiated cells (maintained on MEF-CM plus 10 ng/mL FGF2) was confirmed by qPCR (Fig. 6C) .
Differentiation to trophoblast was increased in the presence of PD173074 or A83-01 and PD173074 (Fig. 6 C-F) , as reflected in the release of hCG and progesterone by the cultured cells assessed at 24-h intervals from day 6, when the production of these hormones was initiated, until day 10 of treatment. Under all three inhibitor treatment conditions, the H1 BP cells produced significantly greater amounts of the two hormones than when the inhibitors were omitted, although both hCG and progesterone were measurable in the hESCM controls, albeit in small amounts (Fig. 6E and Table S6 ). However, although A83-01 promoted only a modest increase relative to controls, PD173074 had a major effect. These effects of PD173074 were much greater on the H1 BP cells than on the H1 cells. Not only were daily amounts of hCG and progesterone enhanced by PD173074 but the onset of detectable production was always earlier than in the controls. Quantification of a CGB + syncytial area on day 10 of treatment was consistent with the ELISA results (Fig. 6I) . Double-staining the colonies for desmoplakin (DSP), a component of functional desmosomes and CGB, indicated that the hCG production was largely limited to cellular regions where the cytoplasm appeared continuous and contained several nuclei (Fig. 6H) , whereas the cells that were negative for CGB contained a single nucleus and were enclosed by a DSP-staining outer surface.
The combination of PD173074 and A83-01 led to a lower production of hCG and progesterone than with PD173074 alone, although amounts under both treatments remained higher than with A83-01 alone. That the H1 BP cells were responding differently to PD173074 than to PD173074 and A83-01 in combination is also illustrated in Fig. 6D . Here, it is clear that CGB and HLA-G expression had been boosted by PD173074, whereas the combination of both drugs led to a much augmented production of HLA-G relative to CGB. These data for CGB are consistent with the qPCR outcomes (Fig. 6C) , where PD173074 alone increased CGB transcript levels ∼10-fold in H1 BP cells relative to H1 cells exposed to the same conditions. qPCR data for HLA-G were more complex but confirmed the enhanced expression in response to PD173074 and A83-01 in combination than with PD173074 alone. Experiments to follow PGF expression (Fig. 6G) confirmed that the control cultures maintained in hESCM produced low amounts (∼100 pg/mL) of hormone and that production was enhanced ∼100-fold with PD173074 and, to a lesser extent, in response to PD173074 and A83-01 together. Comparable results have been obtained with the other cell lines. Fig. S5D , for example, indicates that H9 BP cells also have contrasting responses to PD173074 and to PD173074 and A83-01 together in terms of hCG production. H9 cells, although responding to PD173074 with a later onset of hCG production than H9 BP cells, did produce large quantities of the hormone, particularly by day 10 of culture (compare Fig. 6E with Fig. S5D ). Differences with regard to responses to inhibitors between H1 and H9 ESCs have been noted previously (25) .
Discussion
Our original goal was to isolate trophoblast stem cells from hESCs by brief exposure to BAP. Together, this regimen of factors efficiently drives hESCs to a uniformly KRT7 + state in 48 h (25). The hypothesis was that after about 24 h of treatment, and around the time they became CDX2 + , the cells would be passing through a transient trophoblast stem cell stage before differentiating into more advanced trophoblast lineages. Confidence that this hypothesis was correct was raised when it proved possible to derive colonies from H1 and H9 cells exposed to this differentiation protocol under culture conditions that would not support the growth and passage of the initiating ESCs themselves (Fig. 3 and Fig. S2 ). The cells comprising these colonies also possessed a number of features that initially led us to believe that they might indeed be trophoblast stem cells. For example, under appropriate culture conditions, they were self-renewing and weakly positive for CDX2, and could be readily converted to differentiated cell populations that expressed a suite of trophoblast markers (Fig. 6) . However, it soon became obvious that rather than being trophoblasts, the cells were quite closely related to, but nevertheless distinct from, their pluripotent progenitors (Fig. 3) . In the discussion that follows, we first consider the identities of these cells. Second, we ask whether or not these cells are totipotent. Third, we propose that ESC BP and iPSC BP can potentially provide improved models for following syncytiotrophoblast and extravillous trophoblast differentiation by varying the concentration of PD173074 and A83-01 in the culture medium. Finally, we readdress the ongoing controversy relating to how hESCs and iPSCs might harbor trophoblast potential and discuss the role played by BMP4 in this process. There seems little doubt that H1 BP cells and their H9 and iPSC homologs are pluripotent as gauged by the usual criterion of being able to differentiate along the three main germ cell lineages (Figs. 5 and 6). The undifferentiated BP cells also express the usual transcription factors associated with the pluripotent state and "passed" the PluriTest (37) (Fig. 4) . Nevertheless, the BP cell lines differ in several key respects (Table S1 ) from the cells from which they were derived. In particular, they are morphologically distinct from the initiating ESCs whether they are cultured on Matrigel or gelatin ( Fig. 3 and Fig. S1 ). They can be propagated clonally on gelatin from single cells after trypsin treatment and have transcriptome profiles that distinguish them from their ESC/iPSC teratomas. (Scale bar: 100 μm.) (C) Real-time PCR assessments (n = 3; i.e., three PCR reactions from the same RNA preparation from each teratoma) of relative concentrations of transcripts for HLA-G and CGB in an H1 BP teratoma relative to an H1 teratoma (with GAPDH as an endogenous standard). To provide comparisons, the mean concentration of each transcript in H1 cells has been assigned a value of 1 (**P < 0.01; mean ± SD). (D) Comparisons of hCG concentrations (mIU/mL) in sera of control mice (first column) and mice bearing teratomas from H1, H1 BP , H9, and H9 BP cells (second-fifth columns). Values (mean ± SD) for mice carrying teratomas from H1 BP and H9 BP cells are significantly higher than in controls (*P < 0.05; **P < 0.01), where hCG concentrations for control mice and mice with H1 and H9 teratomas were close to the detection limit of the ELISA.
progenitors (Fig. 4 and Fig. S4 ). The relevance of elevated, somewhat varied expression of several genes encoding transcription factors that may direct trophoblast formation (38-40) (e.g., GATA3, TFAP2A, TFAP2C, CDX2, EOMES) is unclear but might reflect the fact that such cells are hovering on the point of differentiating along that lineage (i.e., transcriptionally primed) as soon as the pluripotent gene networks are down-regulated. Although the observation that CDX2 was coexpressed with POU5F1 in the undifferentiated H1 BP cells might be considered surprising, CDX2 expression has been consistently observed in rat ESCs (41) (42) (43) and associated with POU5F1 expression in human (44) and bovine (45) embryonic trophectoderm. More unexpected was the coexpression of CDX2 with NANOG, because the two transcription factors have mutually antagonistic effects in mouse ESCs and preimplantation embryos (46) . One possible origin of the PSC BP is that they were selected from a small residual population able to survive in a pluripotent state despite exposure (24 h or 36 h) to BAP conditions. Conceivably, such cells existed in a "sporadic superstate" (47) and were already present as a minority population of NANOGoverexpressing cells within the parental ESC and iPSC colonies. Heterogeneity exists in ESC colonies (48) (49) (50) and is evident for NANOG staining of H1 cells (Fig. 3G) . Such heterogeneity is not apparent for H1 BP cells, which are highly homogeneous for Table S6 to demonstrate that measurable amounts of hormone were secreted in the hESCM by both cell types. (H) In the presence of PD173074 (hESCM + P), large areas of syncytiotrophoblasts were detected by double staining for DSP (green) and CGB (red), indicating that the syncytial areas had a continuous cytoplasm and contained multiple nuclei. (I) Quantification of syncytial areas (immunostaining for CGB + ) from H1 and H1 BP cells in four different media (hESCM, hESCM + A, hESCM + P, and hESCM + AP as defined above) for 10 d. CGB + areas from nine frames of each experiment were automatically counted by imageJ software (NIH) and averaged.
NANOG and POU5F1 expression. Moreover, lines resembling H1 BP and H9 BP cell lines cannot be derived directly from parental H1 and H9 cell colonies by simply dispersing the latter to single cells and capturing survivors on a gelatin substratum (Fig.  S2) . Furthermore, our stock populations of ESCs and iPSCs are routinely maintained on mTeSR1 medium, which does not support H1 BP cell self-renewal and would presumably have purged such cells from the population. Accordingly, we believe that such cells arise transiently in response to brief BAP treatment.
Are PSC BP Totipotent? ESCs and iPSCs are considered pluripotent in that they differentiate to all three embryonic germ layers but are not generally believed to be capable of giving rise to extraembryonic tissue, including trophoblast (1). Although the H1 BP cell lines differentiated spontaneously along the three main germ cell lineages in what appears to be a stochastic manner when FGF2 and MEF-CM were withdrawn and replaced with a defined medium that lacked any growth factors, they also readily formed trophoblast (Fig. 6B) . Additionally, H1 BP and H9 BP cells differentiated predominantly, if not completely, to trophoblast when PD173074 alone or in combination with A83-01 was added to the defined ESCM (Fig. 6 C-E) . Interestingly, cell lines with the capacity to contribute to extraembryonic as well as embryonic tissues have been described recently for the mouse (49, 51) . We suggest that both the aforesaid mouse lines and the PSC BP lines described here have achieved a state that is permissive to form trophoblast in addition to differentiated derivatives of the three main germ layers. A number of genes associated with pluripotency are up-regulated in PSC BP , especially LEFTY1, LEFTY2, and NANOG, and could prove to be useful markers of this BMP-primed state. Consistent with this idea were the observations on the H1 BP and H9 BP teratomas, which were composed largely of an array of fetal tissue types (Fig. 5A ) but also included small regions that were trophoblast-like in that they were positive for KRT7 and GATA3 and for KRT7 and CGA, as well as being located adjacent to vacuolar-like spaces that might be analogous to the lacunae present in the immature human placenta (52) (Fig. 5B) . Moreover, the mice carrying tumors from the H1 BP and H9 BP cells had significantly elevated concentrations of hCG in their blood (Fig. 5D ). Care must be taken in evaluating the teratoma data, however. Many human tumors express CGB (53) (54) (55) , and some secrete placental CG and CSH1 (56) , whereas others, including aggressive breast carcinomas, contain areas that are both GATA3 + and KRT7 + (57) . Because the areas of teratomas expressing trophoblast markers were sporadic and not well characterized histologically, the proof that they represent fetal placenta remains weak. In addition, it is clear from the relative amounts of different tissues within the tumors that introduction of the stem cell under the skin of the mice favored differentiation along the three main germ-line images and not to trophoblast.
PSC BP as an Improved Model for Trophoblast Differentiation. The outcomes with different inhibitor combinations on the ESC BP were not identical. With the FGF2-signaling inhibitor (PD173074) alone, markers of syncytiotrophoblast predominated, which represents an outcome quite similar to the outcome observed by Sudheer et al. (20) , who noted that another FGF inhibitor, namely SU5402, in the presence of 10 ng/mL BMP4 drove H1 and H9 cells largely to syncytiotrophoblast. Intriguingly, in our experiments, the presence of the second inhibitor, A83-01, which targets the ALK4, ALK-5, and ALK-7 receptors, and hence ACTIVIN/NODAL/ TGF-β signaling, led to a smaller area of CGB + cells within colonies than PD173074 (Fig. 6I) , reduced the amount of placental hormones released into the medium, and accentuated expression of HLA-G, suggesting that the colonies contained a higher proportion of extravillous trophoblast. Confirming these hypotheses will require additional experiments, but the ability to bias trophoblast differentiation toward either cell type might be of value in understanding the pathobiology of a disease like pre-eclampsia, where placental development appears to be abnormal (58) .
Role for BMP4 in the Generation of Trophoblast from epi-ESCs. We propose that short-term exposure to BMP4 in presence of the two inhibitors causes the PSC to undergo a transition to a "BMPprimed" state, such that the cells remain self-renewing and continue to display a pluripotent signature but are poised to differentiate to trophoblast much more efficiently than if they had not been BMP4-exposed. A somewhat similar role has been envisioned for BMP4 in conserving a stable "ground state" for naive-type stem cells from the mouse (28, 29) , where in association with the growth factor LIF, BMP4 helps preserve the potential of the ESCs for multilineage differentiation, chimera formation, and clonal propagation.
As discussed earlier, the idea that BMP4 can drive hESCs to trophoblast has been controversial (31), despite evidence that both mouse ESCs and hESCs have the potential to differentiate along extraembryonic lineages under appropriate culture conditions (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Moreover, recent evidence suggests that BMP signaling has a role in ensuring the correct development of the trophoblast lineage in preimplantation mouse embryos (59, 60) and that, by the 16-cell morula stage, only the outer cells are fully equipped to respond to signals initiated by BMP4 and related ligands, such as BMP7 (59) . Conceivably, human PSC BP lines are analogous to these outer cells. Their phenotype has been molded by brief BMP exposure, and they remain pluripotent yet can transform to trophoblast as soon as the pluripotent network begins to be down-regulated.
Materials and Methods
Animal Care. All animal experiments were approved by the University of Missouri Institutional Animal Care and Use Committee under Protocol 7170.
Pluripotent Stem Cell Culture. Human H1 (WA01) and H9 (WA09) ESCs were from the WiCell Research Institute, whereas the iPSC line was derived from human umbilical cord fibroblasts reprogrammed with five factors and TP53 shRNA by using episomal plasmid transfection (61) as described by Lee et al. (62) . For routine maintenance, all cell lines were cultured in six-well culture plates (Nunc) coated with Matrigel (BD Bioscience) in the defined mTeSR1 medium, containing FGF2 at 100 ng/mL and 0.6 ng of TGF-β at 0.6 ng/mL (STEMCELL Technologies) (63) , The medium in all wells was changed daily. Cells were passaged at a 1:6 ratio every 5-6 d by using dispase (1 mg/mL; STEMCELL Technologies) for 7 min at 37°C, followed by breakage into small clumps with the Stempro EZpassage (InVitrogen) cutting tool.
Establishing Self-Renewing PSC BP Colonies. To establish the BP self-renewing colonies (Fig. 1A) , H1 cell, H9 cell, hESC, and iPSC colonies were subcultured to provide a transfer of ∼2.4 × 10 4 cells per square centimeter. On the following day, the culture medium was changed from the defined mTeSR1 medium (STEMCELL Technologies) to the standard medium for hESCs (64, 65) , which had been conditioned by a monolayer of γ-irradiated MEF feeder cells (21, 66) containing FGF2 (4 ng/mL). After a further 24 h, the medium was changed to one lacking FGF2 but containing BMP4 (10 ng/mL; R&D Systems), the ALK4/5/7 inhibitor A83-01 (1 μM; Tocris Bioscience), and the FGF2-signaling inhibitor PD173074 (0.1 μM; Sigma-Aldrich) in hESC basal medium not conditioned with MEF feeder cells. Control cultures continued to be grown in the presence of FGF2 and in the absence of BAP. Following this exposure to BMP4 and inhibitors, the culture medium was changed to MEF-CM with FGF2 (10 ng/mL). Culture medium was replenished daily for an additional 2-4 d. On either day 5 or 6, cells were dispersed with TrypLE Express (Gibco) for 3-4 min or with Gentle Cell Dissociation Reagent (STEMCELL Technologies) for 6-7 min at 37°C and transferred to 0.1% gelatin-coated culture dishes. One was to disperse the colonies fully with trypsin for 3-4 min at 37°C. Individual cells were seeded at a density of 1.0 × 10 5 cells per well in a 12-well culture dish. Cells were dispersed and counted on days 4, 5, and 6 by using a TC10 automated cell counter (BioRad). The doubling time was calculated using GraphPad Prism 5 software (online version; GraphPad Software, Inc.). The second method was to count cells visually by using a hemacytometer in 10 different colonies precisely every 24 h on days 3, 4, and 5. Spherical diameters of fully dispersed cell populations were measured with the TC10 automated cell counter.
Teratoma Formation. The cultured ESC BP /iPSC BP and ESCs were dispersed by Gentle Cell Dissociation Reagent (STEMCELL Technologies). After centrifugation (200 × g for 5 min), the cell pellet was resuspended with 0.1 mL of culture medium and chilled on ice before mixing with 0.15 mL of 50% (vol/vol) Matrigel. The solution was loaded into a 1-mL syringe (Becton Dickinson) and injected (∼10 million cells per site) into two sites on 8-to 12-wk-old nonobese diabetic SCID-γ mice (Jackson Laboratories) on their right and left flanks through 22-gauge needles. The resulting tumors were collected between 4 and 8 wk after the cell injection (average of 6.6 ± 0.4 wk, n = 8). After killing the mice, the tumors were dissected out and fixed in 10% (vol/vol) neutral buffered formalin. Paraffin-embedded tissue was sectioned and then stained with H&E. All animal experiments were approved by the University of Missouri Institutional Animal Care and Use Committee under Protocol 7170.
Statistical Analysis. Statistical analyses were performed using GraphPad Prism 5 software. Two-way comparisons on immunoassays were made with the Student's t test. Data followed over time were subjected to one-way ANOVA, followed by the Tukey's test. Values of P ≤ 0.05 were considered to support the conclusion that differences were significant. Fig. 1 but in which the 24-h BAP treatment was omitted (n = 3). (B, Left) At day 4, colonies were fully dispersed by TrypLE proteinase treatment and replated on a gelatin-coated substratum in MEF-CM containing FGF2, and the image was captured before changing the medium. (B, Right) Over the subsequent week, no colonies appeared (after changing the medium) in any of the experiments. The plating efficiency of the H1 cells under these conditions was extremely low, with no measurable cell attachment observed. (C) H1 cells were passaged by dispase treatment, followed by being mechanically dissociated into ∼100-μm cell clusters and plated on either Matrigel-or gelatin-coated substratum. Images were captured the next day before and after changing the medium. H1 colonies were attached on a Matrigelcoated substratum. In contrast, no colonies were attached on a gelatin-coated substratum. . Further analysis of differences in gene expression between H1 and H1 BP cells (related to Fig. 3 and Dataset S1). The analysis of gene expression between H1 and H1 BP cells (at p7 and p18) is assessed by Venn analysis (A) and heat map analysis (B) of microarray data. A total of 255 genes were up-regulated greater than twofold in p7 H1 BP , and a total of 393 genes were up-regulated greater than twofold in p18 H1 BP compared with H1 cells. Among these twofold upregulated genes, 110 were common to both p7 and p18 colonies. Importantly the majority of the genes outside the common set of 110 genes in p7 colonies were also up-regulated in p18 cells but not greater than twofold. The full list of 110 genes up-regulated greater than twofold in both samples is shown in Dataset S1. Table S3 . Primers used for qPCR (related to Fig. 3 )
Gene
Primer sequence Product length, bp Table S6 . Daily production of hCG assayed in culture media over time after differentiating H1 and H1 BP cells under contrasting conditions (related to Fig. 5) 
